[1] Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type Ⅰ and G6Pase-beta deficiency: etiology and therapy[J]. Nat Rev Endocrinol, 2010, 6: 676-688. [2] Rake J, Visser G, Labrune P, et al. Glycogen storage disease type Ⅰ: diagnosis, management, clinical course and outcome. results of the European study on glycogen storage disease type Ⅰ(ESGSDⅠ)[J]. Eur J Pediatr, 2002, 161(Suppl 1): S20-S34. [3] Chou JY, Matern D, Mansfield BC, et al. Type Ⅰ glycogen storage diseases: disorders of the glucose-6-phosphatase complex[J]. Curr Mol Med, 2002, 2: 121-143. [4] Visser G, Rake J, Labrune P, et al. Consensus guidelines for management of glycogen storage disease type 1b-European study on glycogen storage disease type Ⅰ[J]. Eur J Pediatr, 2002, 161(Suppl 1): S120-S123. [5] Wicker C, Célina Roda, Perry A, et al. Infectious and digestive complications in glycogen storage disease type Ib: study of a French cohort[J]. Mol Genet Metab Rep, 2020, 23: 100581. doi:10.1016/j.ymgmr.2020.100581. [6] Barker CC, Butzner JD, Woodman RC, et al. Crohn-like enteritis presenting as hypoglycemia in a patient with glycogen storage disease type 1b, treated with granulocyte colony-stimulating factor and splenectomy[J]. J Pediatr Gastroenterol Nutr, 2001, 32:197-200. [7] Dieckgraefe BK, Korzenik JR, Husain A, et al. Associa-tion of glycogen storage disease 1b and Crohn disease: results of a North American survey[J]. Eur J Pediatr,2002, 161(Suppl 1): S88-S92. [8] Dale DC, Bolyard AA, Marrero T, et al. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor[J]. Curr Opin Hematol, 2019, 26: 16-21. [9] Davis MK, Rufo PA, Polyak SF, et al. Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib[J]. J Inherit Metab Dis, 2008, 31(Suppl 3): 505-509. |